?????? ?? ??? ??ᵗʰ ?????? ?????????? ?? ??? ?????????’? ??????? ??????????? ?? ??? ???????????!
Over the last weekend, Moleac attended the 17ᵗʰ Annual Convention of the Alzheimer’s Disease Association of the Philippines together with our valued partner in the Philippines, E*Chi’mes Pharmaceutical Inc.
This year, the theme was “Silver Linings: Connecting the Dots in Dementia Care”. Through the two-day event, dementia specialists, allied health professionals, industry partners and more from all over the country were brought together to discuss the latest developments in the rapidly-evolving field of Alzheimer’s Disease research, share knowledge and foster deeper relationships.
Dr. Donnabelle M. Chu, specialist neurologist in Behavioral Neurology & Dementia, delivered a presentation on “The Role of NeuroAiD in the Management of Alzheimer’s Disease: Exploring Safety, Efficacy and Potential Disease-Modifying Effect” during the lunch symposium on Day 2 of the convention, summarizing the pre-clinical data and clinical trial results on NeuroAiD in Alzheimer’s Disease. Her presentation was warmly received and encouraged a lively discussion on the potential of NeuroAiD in dementia. Afterwards, our CEO David Picard delivered a rousing speech on how NeuroAiD can play an important role in the treatment toolkit for Alzheimer’s Disease.
Moleac was honoured to be given the opportunity to connect with the multi-disciplinary network of dementia specialists attending the conference and to work together with the dementia community at large to advance care in Alzheimer’s Disease.
We would like to thank E*Chi’mes Pharmaceutical Inc for your continued partnership and commitment to patient care.
Learn more about our role in Alzheimer’s Disease care at moleac.com.
